CE-245677

N/A

Report date: 2022/01/14 13:23:58

NME

Base Information

Drug NameCE-245677

Drug Alias NameCE-245677

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTEK receptor tyrosine kinase antagonistsNerve growth factor receptor Trk-A antagonistsNeurotrophic tyrosine kinase receptor type 2 inhibitors +[4]

TargetsNeurotrophic tyrosine kinase receptor type 3Nerve growth factor receptor Trk-ANeurotrophic tyrosine kinase receptor type 2 +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A